Combination effect of doxorubicin and HIF inhibitor on MCF-7 CD44+/CD24- subpopulation cells in hypoxic condition. Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 58, 2022. DOI: 10.1590/s2175-97902020000318754 . Disponível em: https://periodicos.usp.br/bjps/article/view/205856.. Acesso em: 2 jun. 2024.